previous compound ID: 356 next compound
InChIKey: CMWTZPSULFXXJA-VIFPVBQESA-N
SMILES: C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "R Robert" "D Rotin" "GW Carlile" "E Matthes" "J Liao" "DY Thomas" "JW Hanrahan" "B Kus" "SD Macknight"

chemical graph of compound 356





CID is 156391
synonyms found at PubChem are:
NAPROXEN, 22204-53-1, (S)-Naproxen, Naprosyn, Naproxene, (+)-Naproxen, Equiproxen, Aleve, Laraflex, Naproxeno, Naproxenum, d-Naproxen, (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid, (S)-(+)-Naproxen, Calosen, Naprosyne, Nycopren, Bonyl, Naixan, Reuxen, Axer, (+)-(S)-Naproxen, Ec-Naprosyn, (S)-2-(6-methoxynaphthalen-2-yl)propanoic acid, Acusprain, Anexopen, Arthrisil, Artrixen, Artroxen, Bipronyl, Clinosyn, Danaprox, Flexipen, Leniartil, Novonaprox, Anaprox, Apronax, Artagen, Atiflan, Congex, Daprox, Genoxen, Lefaine, Nafasol, Nalyxan, Napflam, Napmel, Naposin, Napren, Naprius, Fuxen, Naxen, Naxyn, Dysmenalgit N, Apo-Naproxen, (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid, Veradol, Xenar, Floginax, Headlon, Napratec, Naprontag, Narocin, Naxopren, Prafena, Priaxen, Pronaxen, Rheumaflex, Saritilron, Sinartrin, Soproxen, Sutolin, Tohexen, Traumox, Flexen, Napxen, Noflam, Patxen, Rahsen, Sinton, Sutony, Velsay, Vinsen, Methoxypropiocin, Narma, Roxen, Anax, (S)-2-(6-Methoxy-2-naphthyl)propionic acid, Flanax Forte, (+)-2-(6-Methoxy-2-naphthyl)propionic acid, Naprosyn LLE, Napren E, Proxen LE, Naxen F, Proxen LLE, U-Ritis, (+)-2-(Methoxy-2-naphthyl)-propionic acid, RS-3540, Naprelan, Naprosyn LLE Forte, Naproxi 250, Naproxi 500, (S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, Naxyn 250, Naxyn 500, (S)-2-(6-Methoxy-2-naphthyl)propanoic acid, Equiproxen (Veterinary), Apo-Napro-NA, (S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, Naproxene [INN-French], Naproxenum [INN-Latin], Naproxeno [INN-Spanish], d-2-(6-Methoxy-2-naphthyl)propionic acid, (+)-2-(Methoxy-2-naphthyl)-propionsaeure, naproxen(+), UNII-57Y76R9ATQ, (+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, Dysmenalgit, Diocodal, Prexan, Proxen, CG 3117, CCRIS 5265, CHEBI:7476, HSDB 3369, EINECS 244-838-7, CHEMBL154, RS 3540, 57Y76R9ATQ, d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure, (2S)-2-(6-methoxy-2-naphthyl)propanoic acid, CMWTZPSULFXXJA-VIFPVBQESA-N, Naprium, Naprux, Laser, (+)-2-(Methoxy-2-naphthyl)-propionsaeure [German], (+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, Propionic acid, 2-(6-methoxy-2-naphthyl)-, (+)-, d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure [German], Duk, 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)-, 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (S)-, CAS-22204-53-1, Naprosine, Panoxen, Proxine, Mnpa, (S)-2-(6-Methoxy-naphthalen-2-yl)-propionic acid, 26159-31-9, (S)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid, DL Naproxen, Naprosin, Xenar-CR, aproxen, 2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (S)-, Naprolag, Naprosy, SR-01000075977, 2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (.alpha.S)-, Naproxen [USAN:BAN:INN:JAN], Naprosyn (TN), Naproxen,(S), NPS, Prestwick_349, Naproxen [USAN:USP:INN:BAN:JAN], PubChem8102, Spectrum_000977, 4or0, 4po0, (S)-(+)-Naproxene, Prestwick0_000791, Prestwick1_000791, Prestwick2_000791, Spectrum2_001043, Spectrum3_000514, Spectrum4_000069, Spectrum5_001327, (+)NAPROXEN, Naproxen2-(6-Methoxy-naphthalen-2-yl)-propionic acid, D0DJ1B, D0S2QI, Epitope ID:139974, UPCMLD-DP001, 2-(6-Methoxy-naphthalen-2-yl)-propionic acid(Naproxen), EC 244-838-7, AC1L4G3X, AC1Q4ET9, AC1Q4F4H, AC1Q4F4I, SCHEMBL3046, DSSTox_CID_20686, DSSTox_RID_79542, DSSTox_GSID_40686, Lopac0_000792, BSPBio_002067, KBioGR_000597, KBioSS_001457, KSC911E2L, ARONIS24306, BIDD:GT0062, DivK1c_000242, SPECTRUM1500425, Naproxen (JP17/USP/INN), SPBio_000966, SPBio_002861, GTPL5230, DTXSID4040686, UPCMLD-DP001:001, CMWTZPSULFXXJA-VIFPVBQESA-, CTK8B1225, HMS500M04, KBio1_000242, KBio2_001457, KBio2_004025, KBio2_006593, KBio3_001567, KS-00002WWU, Naproxen 1.0 mg/ml in Methanol, MolPort-000-145-960, NINDS_000242, HMS1920P13, HMS2089N21, HMS2091H12, HMS3649M13, Pharmakon1600-01500425, ZINC105216, ACT02593, Tox21_301953, ANW-24773, BDBM50339185, CCG-40130, MFCD00010500, NSC750183, NSC757239, AKOS005267223, AC-1363, CS-2163, DB00788, MCULE-2589082817, ME-0100, NSC-750183, NSC-757239, RP27889, RTR-010461, IDI1_000242, NCGC00016759-01, NCGC00016759-02, NCGC00016759-03, NCGC00021127-01, NCGC00161591-01, NCGC00255562-01, AJ-11169, AN-14988, BC208049, BR-72928, HY-15030, SC-02561, SY015060, (+)-2-(Methoxy-2-naphthyl)-propionsaure, Naproxen, meets USP testing specifications, SBI-0050769.P004, AB1009325, LS-124738, ST2408284, TL8003659, AM20060551, FT-0082415, FT-0602835, M1021, W4580, Naproxen, VETRANAL(TM), analytical standard, (S)-2-(6-methoxy-2-naphthyl)-propionic acid, 04N531, C01517, D00118, J10145, M-5280, (2S)-2-(6-methoxy(2-naphthyl))propanoic acid, AB00052049-04, AB00052049_05, (+)(S)2-(6-methoxy-2-naphthyl)-propionic acid, 2-(6-Methoxy-2-naphthyl)propanoic acid , (+)-, SR-01000003110, Q-201447, SR-01000003110-5, SR-01000075977-3, SR-01000075977-4, (+)-6-Methoxy-.alpha.-methyl-2-napthaleneacetic acid, BRD-K59197931-001-02-9, BRD-K59197931-001-03-7, BRD-K59197931-236-09-6, SR-01000075977-10, (+)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid, (alphas)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid, (S)-()-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, (S)-(+)-2-(6-methoxy-naphthalen-2-yl)-propionic acid, (S)-6-Methoxy-.alpha.-methyl-2-naphthalene acetic acid, Naproxen, British Pharmacopoeia (BP) Reference Standard, Naproxen, European Pharmacopoeia (EP) Reference Standard, (S)-(+)-6-Methoxy-alp.-methyl-2-naphthalene acetic acid, (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid; Naproxen, (S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, 98%, 2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (+)-, Naproxen, United States Pharmacopeia (USP) Reference Standard, 2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)- (8CI), Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material, Naproxen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, InChI=1/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1